{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:56:19Z","timestamp":1773327379916,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.amepre.2024.10.004","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:58:43Z","timestamp":1729144723000},"page":"272-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic Opioid Use After Implementation of Oregon's Medicaid Back Pain Policy"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0685-773X","authenticated-orcid":false,"given":"Daniel M.","family":"Hartung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7825-5121","authenticated-orcid":false,"given":"Sanae","family":"El Ibrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6190-6565","authenticated-orcid":false,"given":"Catherine J.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina J.","family":"Charlesworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. John","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther K.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.amepre.2024.10.004_bib0001","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1097\/01.brs.0000244618.06877.cd","article-title":"Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002","volume":"31","author":"Deyo","year":"2006","journal-title":"Spine (Phila Pa; 2006)"},{"issue":"9","key":"10.1016\/j.amepre.2024.10.004_bib0002","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"U.S. health care spending by payer and health condition, 1996\u20132016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.amepre.2024.10.004_bib0003","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.2018.0158","article-title":"The state of U.S. health, 1990\u20132016: burden of diseases, injuries, and risk factors among U.S. states","volume":"319","author":"Mokdad","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amepre.2024.10.004_bib0004","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/M16-2458","article-title":"Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline","volume":"166","author":"Chou","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.amepre.2024.10.004_bib0005","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/AJP.0000000000000603","article-title":"Depression effects on long-term prescription opioid use, abuse, and addiction","volume":"34","author":"Sullivan","year":"2018","journal-title":"Clin J Pain"},{"issue":"3","key":"10.1016\/j.amepre.2024.10.004_bib0006","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.amepre.2024.10.004_bib0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.amepre.2024.10.004_bib0008","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14740338.2016.1177509","article-title":"Safety concerns with long-term opioid use","volume":"15","author":"Harned","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.amepre.2024.10.004_bib0009","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.amepre.2024.10.004_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the U.S. opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"7","key":"10.1016\/j.amepre.2024.10.004_bib0011","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.spinee.2011.03.017","article-title":"Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care","volume":"11","author":"Ivanova","year":"2011","journal-title":"Spine J"},{"issue":"17","key":"10.1016\/j.amepre.2024.10.004_bib0012","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jamainternmed.2013.8992","article-title":"Worsening trends in the management and treatment of back pain","volume":"173","author":"Mafi","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.amepre.2024.10.004_bib0013","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2024.10.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107563","article-title":"Evidence for state, community and systems-level prevention strategies to address the opioid crisis","volume":"204","author":"Haegerich","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.amepre.2024.10.004_bib0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/M16-2367","article-title":"Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.amepre.2024.10.004_bib0016","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1007\/s11606-019-05086-4","article-title":"VA\/DoD Clinical practice guideline: diagnosis and treatment of low back pain","volume":"34","author":"Pangarkar","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.10.004_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1468-0009.12436","article-title":"The association of state opioid misuse prevention policies with patient- and provider-related outcomes: a scoping review","volume":"98","author":"Mauri","year":"2020","journal-title":"Milbank Q"},{"issue":"2","key":"10.1016\/j.amepre.2024.10.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0235","article-title":"Prescription drug coverage for treatment of low back pain among U.S. Medicaid, Medicare Advantage, and commercial insurers","volume":"1","author":"Lin","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.amepre.2024.10.004_bib0019","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1001\/jamainternmed.2021.4281","article-title":"Association of state opioid prescription duration limits with changes in opioid prescribing for Medicare beneficiaries","volume":"181","author":"Cramer","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amepre.2024.10.004_bib0020","series-title":"Annual surveillance report of drug-related risks and outcomes\u2014United States. Surveillance special report","year":"2018"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2024.10.004_bib0021","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1089\/acm.2018.0431","article-title":"Whole systems within whole systems: the Oregon health Plan's expansion of services for back and neck pain","volume":"25","author":"Eaves","year":"2019","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.amepre.2024.10.004_bib0022","unstructured":"Oregon Health Authority, Health Evidence Review Committee. Back policy changes fact sheet. Salem, OR: Oregon Health Authority, Health Evidence Review Committee. https:\/\/www.oregon.gov\/oha\/HPA\/DSI-HERC\/FactSheets\/Back-policy-changes-fact-sheet.pdf. Published August 25, 2016. Accessed January 12, 2024."},{"issue":"3","key":"10.1016\/j.amepre.2024.10.004_bib0023","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s11606-020-06352-6","article-title":"Increased use of complementary and alternative therapies for back pain following statewide Medicaid coverage changes in Oregon","volume":"36","author":"Choo","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2024.10.004_bib0024","unstructured":"Oregon Health Authority. HERC removes OHP opioid tapering requirement for neck and back pain. Salem, OR: Oregon Health Authority. https:\/\/www.oregon.gov\/oha\/ERD\/Pages\/HERCRemovesOHPOpioidTaperingRequirementNeckBackPain.aspx. Published May 16, 2019. Accessed January 12, 2024."},{"issue":"2","key":"10.1016\/j.amepre.2024.10.004_bib0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3122\/jabfm.2022.02.210306","article-title":"Reduction of long-term opioid prescribing for back pain in community health centers after a Medicaid policy change","volume":"35","author":"Muench","year":"2022","journal-title":"J Am Board Fam Med"},{"issue":"9","key":"10.1016\/j.amepre.2024.10.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13431","article-title":"Assessment of opioid prescribing patterns in a large network of U.S. community health centers, 2009 to 2018","volume":"3","author":"Muench","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.amepre.2024.10.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.0634","article-title":"Changes in buprenorphine prescribing in community health centers","volume":"5","author":"Hartung","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"3","key":"10.1016\/j.amepre.2024.10.004_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.1016\/j.amepre.2024.10.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008\u20132017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.amepre.2024.10.004_bib0030","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/pm\/pnaa470","article-title":"Longitudinal dose trajectory among patients tapering long-term opioids","volume":"22","author":"Fenton","year":"2021","journal-title":"Pain Med"},{"key":"10.1016\/j.amepre.2024.10.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111277","article-title":"Impact of overdose on health plan disenrollment among patients prescribed long-term opioids: retrospective cohort study","volume":"258","author":"Fenton","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.amepre.2024.10.004_bib0032","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/j.pain.0000000000002298","article-title":"Patient outcomes following opioid dose reduction among patients with chronic opioid therapy","volume":"163","author":"Hallvik","year":"2022","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.amepre.2024.10.004_bib0034","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.amepre.2024.10.004_bib0035","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2105\/AJPH.2004.042432","article-title":"Rural definitions for health policy and research","volume":"95","author":"Hart","year":"2005","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.amepre.2024.10.004_bib0036","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJMsa1807069","article-title":"Initial opioid prescriptions among U.S. commercially insured patients, 2012\u20132017","volume":"380","author":"Zhu","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.10.004_bib0037","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41598-024-52032-4","article-title":"Reductions in sustained prescription opioid use within the U.S. between 2017 and 2021","volume":"14","author":"Schoenfeld","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.amepre.2024.10.004_bib0038","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12913-022-07477-6","article-title":"Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions","volume":"22","author":"Hartung","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.amepre.2024.10.004_bib0039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.addbeh.2018.04.020","article-title":"A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations","volume":"86","author":"Hartung","year":"2018","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.amepre.2024.10.004_bib0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PHH.0000000000000849","article-title":"Integrating public health and health care strategies to address the opioid epidemic: the Oregon health authority's opioid initiative","volume":"25","author":"Hedberg","year":"2019","journal-title":"J Public Health Manag Pract"},{"issue":"9","key":"10.1016\/j.amepre.2024.10.004_bib0041","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jama.2016.0206","article-title":"Oregon's Medicaid coordinated care organizations","volume":"315","author":"McConnell","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amepre.2024.10.004_bib0042","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5055\/jom.0811","article-title":"Analgesic methadone prescribing in community health centers among patients with chronic pain","volume":"19","author":"Bailey","year":"2023","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.amepre.2024.10.004_bib0043","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221147378","article-title":"Sedative-hypnotic co-prescribing with opioids in a large network of community health centers","volume":"14","author":"Hartung","year":"2023","journal-title":"J Prim Care Community Health"},{"issue":"6","key":"10.1016\/j.amepre.2024.10.004_bib0044","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 Opioid Guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amepre.2024.10.004_bib0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11606-019-05445-1","article-title":"Primary care opioid taper plans are associated with sustained opioid dose reduction","volume":"35","author":"D Sullivan","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.amepre.2024.10.004_bib0046","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.japh.2020.12.019","article-title":"Factors associated with opioid-tapering success: a mixed methods study","volume":"61","author":"Kuntz","year":"2021","journal-title":"J Am Pharm Assoc JAPhA"},{"issue":"5","key":"10.1016\/j.amepre.2024.10.004_bib0047","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2024.10.004_bib0048","doi-asserted-by":"crossref","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in U.S. veterans: observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.amepre.2024.10.004_bib0049","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/M19-1488","article-title":"Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine","volume":"171","author":"Chou","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2024.10.004_bib0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40615-023-01555-z","article-title":"Examining racial\/ethnic differences in patterns of opioid prescribing: results from an urban safety-net healthcare system","volume":"11","author":"Flores","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"issue":"4","key":"10.1016\/j.amepre.2024.10.004_bib0051","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMsa2034159","article-title":"Racial inequality in prescription opioid receipt - role of individual health systems","volume":"385","author":"Morden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2024.10.004_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109108","article-title":"Long-term opioid therapy tapering: trends from 2014 to 2018 in a Midwestern State","volume":"228","author":"Mazurenko","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2024.10.004_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103888","article-title":"U.S. state policies on opioid prescribing during the peak of the prescription opioid crisis: associations with opioid overdose mortality","volume":"110","author":"Buonora","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2024.10.004_bib0054","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-024-08776-w","article-title":"Outcomes after a statewide policy to improve evidence-based treatment of back pain among Medicaid enrollees in Oregon","author":"Choo","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1016\/j.amepre.2024.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.4254","article-title":"Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program","volume":"26","author":"Hartung","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2024.10.004_bib0056","first-page":"4049","article-title":"Association between opioid overdose and health plan disenrollment with mitigating impact of buprenorphine initiation","volume":"21","author":"Fenton","year":"2021","journal-title":"Ann Fam Med"},{"issue":"10","key":"10.1016\/j.amepre.2024.10.004_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34671","article-title":"Opioid dose trajectories and associations with mortality, opioid use disorder, continued opioid therapy, and health plan disenrollment","volume":"5","author":"Binswanger","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724003507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724003507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T01:29:11Z","timestamp":1737595751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379724003507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0749379724003507"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2024.10.004","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Opioid Use After Implementation of Oregon's Medicaid Back Pain Policy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2024.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}